DexCom DXCM

DexCom trades at 6.2x EV/NTM revenue on a $34.41B enterprise value. Revenue grew 13.1% year over year to $1.31B in the quarter ending June 2026, an annual run rate of $5.23B. DexCom reports a 63.4% gross margin.

ARR ($M)
Net Dollar Retention
--
ARR Growth
--
EV / NTM Revenue
6.2x
Payback Period
EV / Run Rate
6.6x
Price & Key Metrics
Price Performance
Company Details
Share Price: 90.82
Last Filing Date: 2026-06-30
Last Filing: Form
Founding Year: 1999
IPO Year: 2005
% of 52 wk High: 98%
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions.
Categories
Healthcare Healthtech Healthcare Services
Valuation
Market Cap: 34,271.905
Enterprise Value: 34,409.705
EV / Revenue Run Rate: 6.6x
EV / NTM Revenue: 6.2x
EV / 2026 Revenue Estimates: 6.6x
EV / 2027 Revenue Estimates: 5.9x
EV / 2028 Revenue Estimates: 5.3x
Key Business Metrics
Net Dollar Retention: --
Customers: --
ARR: --
ARR Growth %: --
ARR/Customer ($K): --
ARR/Employee ($K): --
Revenue
Revenue Run Rate: 5,233
ARR: --
2026 Revenue Estimates: 5,218
2027 Revenue Estimates: 5,839
2028 Revenue Estimates: 6,451
LTM Revenue: 4,969
Last Year Run Rate: 4,628
Growth
Revenue Growth: 13%
ARR Growth: --
Growth Persistence: 86%
2026 Revenue Growth Estimates: 12%
2027 Revenue Growth Estimates: 12%
2028 Revenue Growth Estimates: 10%
Financials
Quarterly
Calendar Year
Frequently Asked Questions

How fast is DexCom growing?

DexCom grew revenue 13.1% year over year, reaching $1.31B in the quarter ending June 2026.

What multiple does DexCom trade at?

DexCom trades at 6.2x EV/NTM revenue and 6.6x EV/run-rate, on an enterprise value of $34.41B.

Is DexCom profitable?

For DexCom, operating income was $318.3M last quarter and LTM free cash flow margin is 28.3%.

What sector is DexCom in?

Public Comps classifies DexCom under Healthcare, Healthtech, and Healthcare Services.

Where does Public Comps get DexCom's data?

Figures come from DexCom's own SEC filings, normalised into a consistent quarterly format and refreshed after each earnings release.